NCT05757414Completed
Lighting Intervention to Improve Sleep
Dissecting Oligogenic Biomarkers in Parkinson Disease
Source: ClinicalTrials.gov · Last updated 16 Jul 2025
Brief summary (registry, in English)
50 participants with Parkinson's disease will be recruited to complete actigraphy studies to assess sleep disturbances. For this, participants will wear an Actigraph for seven days. Thirty of these participants with sleep disturbance, will go on to receive a tailored lighting intervention (TLI) to assess the effect on sleep, fatigue, and circadian entrainment via urinary melatonin levels.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 57 (actual)
- First submitted
- 21 Feb 2023
- Start date
- 16 Nov 2021
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Parkinson disease
- NCT number
- NCT05757414
What you commit to
- Study type: Interventional
- Participants enrolled: 57
- From 16 Nov 2021 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There is no exclusion criteria
Who the study is looking for
- Diagnosis of Parkinson's disease and
- Difficulties with sleep or cognition
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mount Sinai Beth Israel Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.